Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $12.8 million.

  • Ultralife's Other Accumulated Expenses rose 4415.2% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 4415.2%. This contributed to the annual value of $9.5 million for FY2024, which is 3010.03% up from last year.
  • Ultralife's Other Accumulated Expenses amounted to $12.8 million in Q3 2025, which was up 4415.2% from $8.8 million recorded in Q2 2025.
  • Ultralife's Other Accumulated Expenses' 5-year high stood at $12.8 million during Q3 2025, with a 5-year trough of $4.0 million in Q2 2021.
  • For the 4-year period, Ultralife's Other Accumulated Expenses averaged around $7.4 million, with its median value being $6.9 million (2023).
  • Per our database at Business Quant, Ultralife's Other Accumulated Expenses plummeted by 87.1% in 2021 and then skyrocketed by 4415.2% in 2025.
  • Ultralife's Other Accumulated Expenses (Quarter) stood at $6.1 million in 2021, then grew by 19.8% to $7.3 million in 2023, then surged by 30.1% to $9.5 million in 2024, then surged by 35.35% to $12.8 million in 2025.
  • Its Other Accumulated Expenses stands at $12.8 million for Q3 2025, versus $8.8 million for Q2 2025 and $8.6 million for Q1 2025.